Bahamas
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Bahamas (BS)
2000 | 15.6 thousand |
2011 | 28.8 thousand |
2024 | 26.8 thousand |
2050 | 36.5 thousand |
Bahamas is one of the 22 countries and territories in the IDF North America and Caribbean Region.
Data source(s) used for the diabetes estimates in adults:
- WHO STEPs Bahamas 2011
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 15.6 | 28.8 | 26.8 | 36.5 |
Age-standardised prevalence of diabetes, % | - | 12.1 | 8.9 | 10.0 |
Proportion of people with undiagnosed diabetes, % | - | - | 24.5 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 6.6 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 12.4 | 15.1 |
Age-standardised prevalence of IFG, % | - | - | 4.1 | 4.3 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 25.2 | 16.7 | 22.3 |
Age-standardised prevalence of IGT, % | - | 10.6 | 5.6 | 6.2 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 292.0 | 344.5 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 14.9 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 65.5 | 73.4 |
Total diabetes-related health expenditure, ID million | - | - | 65.3 | 73.1 |
Diabetes-related health expenditure per person, USD | - | 2,056.0 | 2,449.6 | 2,010.6 |
Diabetes-related health expenditure per person, ID | - | - | 2,439.7 | 2,002.5 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 341.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 65.1 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 183.0 | 235.9 | 300.1 | 333.5 |
Population of children and adolescents (0-19 y) | - | - | 100,565.0 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 15.6 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 183.0 |
Population of children and adolescents (0-19 y) | - |